Clinique Mathilde

Rouen 9 trials 4 recruiting

9 Registered trials

4 Currently recruiting

Organisation

Clinique Mathilde

Location

Rouen, France

Identifier

ORG-100048345

Address

7 Boulevard De L Europe, 76100, France

Departments

250006: Service Ophtalmologie
Chirurgie gynécologique
Clinique Mathilde; Ophtalmologie
Medical oncology
Oncology
Ophtalmologie
Ophtalmology

Clinical trials at this site (9)

Search interface

Long–term Analysis of DImethyl fumarate, to slow the Growth of Areas of Geographic Atrophy Recruiting

2024-510741-33-00 Macular degeneration 4 2024-06-27
ENGIC 06 (PRODIGE 114) – FFCD 2401 – FRUQUITAS Randomized phase III trial to compare trifluridine/tipiracil + Fruquintinib versus triflurid… Recruiting

2025-522395-92-00 metastatic oeso-gastric adenocarcinoma 5 2025-12-15
A study Investigating Subcutaneously Administered Pozelimab in Combination with Cemdisiran or Cemdisiran Alone in Adult Participants with Ge… Recruiting

2023-509547-27-00 Geographic Atrophy Secondary to Age-Related Macular Deg 5 2025-05-22
LOADEX: PILOT AND PHASE 2 STUDY OF THE EFFICACY OF A TREATMENT PROTOCOL WITH DEXAMETHASONE IMPLANT LOADING DOSE IN PATIENTS WITH DIABETIC MA… Recruiting

2024-514362-39-00 Diabetic macular oedema 4 2019-12-05
PRODIGE 85 (FFCD 1804) – KANALRAD Prospective randomized phase III study evaluating induction chemotherapy (modified DCF 4 cycles) followed… Ended

2023-505972-32-00 locally advanced anal squamous cell carcinoma 5 2024-02-26
A Study to Evaluate Long-Term Safety and Tolerability of the Port Delivery System with Ranibizumab in Patients with Neovascular Age-Related … Ended

2023-507131-38-00 Neovascular Age-Related Macular Degeneration (nAMD) 5 2022-05-16
Phase III randomized clinical trial evaluating hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer considering two different… Ended

2024-514706-31-01 Epithelial ovarian cancer, Fallopian tube ovarian cance 5 2019-05-02
Chemotherapy or chemotherapy + hormonotherapy in women over 70 with HER2 receptor-negative but estrogen receptor-positive breast cancer acco… Ended

2024-516996-34-00 oestrogen-receptor (ER)-positive HER2-negative breast c 5 2012-04-12
Comparative multicenter randomized study of aflibercept versus placebo in macular telangiectasia type 1 Ended

2024-511885-35-00 macular telangiectasia type 1 5 2019-07-03